Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1993-07-29
1997-05-13
Bawa, Raj
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424465, 424468, 424469, 424484, A61K 920
Patent
active
056290160
ABSTRACT:
A water-dispersible tablet comprises acyclovir and a dispersing agent. The dispersing agent is a swellable clay such as a smectite e.g., Veegum F or bentonite, and is present within the granules of the tablet to provide a tablet which is capable of dispersing in water within 3 minutes to provide a dispersion which will pass through a 710 .mu.m sieve. The tablet also includes a cellulostic excipient. The tablet can be optionally film-coated, in which case the dispersion time is less than 5 minutes.
REFERENCES:
patent: 3427379 (1969-02-01), Barry et al.
patent: 3432593 (1969-03-01), Shepard
patent: 3567819 (1971-03-01), Leonia et al.
patent: 4072535 (1978-02-01), Short et al.
patent: 4086335 (1978-04-01), Bruscato et al.
patent: 4159345 (1979-06-01), Takeo et al.
patent: 4209513 (1980-06-01), Torode et al.
patent: 4251518 (1981-02-01), Moore et al.
patent: 4304773 (1981-12-01), Wong et al.
patent: 4305502 (1981-12-01), Gregory et al.
patent: 4322449 (1982-03-01), Voss et al.
patent: 4369308 (1983-01-01), Trubiano
patent: 4371516 (1983-02-01), Gregory et al.
patent: 4414198 (1983-11-01), Michaelson
patent: 4517179 (1985-05-01), Raghunathan
patent: 4600579 (1986-07-01), Salpekar et al.
patent: 4602017 (1986-07-01), Sawyer et al.
patent: 4631305 (1986-12-01), Guyer et al.
patent: 4661521 (1987-04-01), Salpekar et al.
patent: 4711777 (1987-12-01), Tan et al.
patent: 4757090 (1988-07-01), Salpekar et al.
patent: 4774083 (1988-09-01), Tan et al.
patent: 4781925 (1988-11-01), Michelucci et al.
patent: 4832956 (1989-05-01), Gergely et al.
patent: 4837031 (1989-06-01), Denton
patent: 4847249 (1989-07-01), Sawyer et al.
patent: 4904477 (1990-02-01), Ho et al.
patent: 4910023 (1990-03-01), Botzolakis et al.
patent: 4925676 (1990-05-01), Sellassie et al.
patent: 4927639 (1990-05-01), Sellassie et al.
patent: 4950484 (1990-08-01), Olthoff et al.
patent: 4965072 (1990-10-01), Alexander et al.
patent: 4968517 (1990-11-01), Gergely et al.
patent: 4970078 (1990-11-01), Holinej
patent: 4999200 (1991-03-01), Casillan
patent: 5006345 (1991-04-01), Lang
patent: 5037658 (1991-08-01), Urban et al.
patent: 5047247 (1991-09-01), Milovac et al.
patent: 5049586 (1991-09-01), Ortega et al.
patent: 5064656 (1991-11-01), Gergely et al.
patent: 5069910 (1991-12-01), Kovacie et al.
patent: 5073377 (1991-12-01), Alexander et al.
patent: 5085869 (1992-02-01), Olthoff et al.
patent: 5087454 (1992-02-01), Duerholz et al.
patent: 5136080 (1992-08-01), Miller et al.
Wai, et al., "Applications of the Montmorillonites in Tablet Making," J. Pharm. Sci., 55: 1244-1248 (1966).
Wai & Banker, "Some Physicochemical Properties of the Montmoril-lonites," J. Pharm. Sci., 55: 1215-1220 (1966).
Granberg, et al., "The Use of Dried Bentonite as a Disintegrat-ing Agent in Compressed Tablets of Thyroid," J. Am. Pharm. Assoc. Sci., 43: 648-651 (1949).
Gross, et al., "A Comparative Study of Tablet Disintegrating Agents," J. Am. Pharm. Assoc. Sci., 41: 157-161 (1952).
Firouzabadian, et al., "Some Recently Developed Chemicals as Disintegrating Agents for Compressed Tablets," J. Am. Pharm. Assoc. Sci., 43: 248-250 (1954).
Ward, et al., "Evaluation of Tablet Disintegrants," Drug Cosmetic Ind. 91: 35-36, 92, 110-111 (1962).
Nair, et al., "Studies on Disintegration of Compressed Tablets I. Effect on Disintegration of the Procedure Used in Incorporating the Disintegrating Agent," J. Am. Pharm. Assoc. Sci., 46: 131-134 (1957).
Patel, et al., "Veegum as Binding Agent for Compressed Tablets," Indian J. Pharm., 19: 4-10 (1957).
Feinstein, et al., "Comparative Study of Selected Disintegrating Agents," J. Pharm. Sci. 55: 332-334 (1966).
Varley, A., "The Generic Inequivalence of Drugs," JAMA, 206: 1745-1748 (1968).
Delonca, et al., "Study of the Activity of Some Disintegrants as a Function of Procedure and of the Solubility of the Active Principles," J. Pharm. Belg. 26(4): 447-458 (1971) - English Translation.
Wagner, et al., "In Vivo and In Vitro Availability of Commercial Warfarin Tablets," J. Pharm. Sci. 60: 666-677 (1971).
McGinty, et al., "Optimization of Slow-Release Tablet Formulations Containing Montmorillonite I. Properties of Tablets," Drug Development and Industrial Pharmacy 6: 399-410 (1980).
Bargava, et al., "An Evaluation of Smecta as a Tablet Disintegrant and Dissolution Aid," Drug Development and Industrial Pharmacy 17: 2093-2102 (1991).
Barr, M., "In Pharmaceutical Systems . . . Clays as Dispersion Stabilizers," J. Amer. Pharm. Assoc. Sci. Ed. 46: 486-493.
US Pharmacopoeia, pp. 579, 1573, 1574, 1534 and 1535 (1985).
British Pharmacopoeia, pp. 27, 28, 51, 52, 62, 323-325 (1985).
Martindale, The Extra Pharmacopoeia, 29th Edition, pp. 4, 1077, 1092 and 1433.
The Handbook of Pharmaceutical Excipients, pp. 9-11, 150-152, 166-169.
Armstrong, N., "Tableting" from Pharmaceutics: The Science of Dosage Form Design, (Ed. Aulton): 647-668 (1988).
Rubinstein, M., "Tablets" from Pharmaceutics: The Science of Dosage Form Design, (Ed. Aulton): 304-321 (1988).
Rudnic, et al., "Oral Solid Dosage Forms," from Remington's Pharmaceutical Sciences (ed. Gennaro), pp. 1633-1665 (1990).
Disanto, A., "Bioavailability and Bioequivalency Testing," from Remington's Pharmaceutical Sciences (ed. Gennaro), pp. 1451-1458 (1990).
Banker, et al., "Tablets," from The Theory and Practice of Industrial Pharmacy, pp. 293-345.
Marshall, et al., "Tablet Dosage Forms," from Modern Pharmaceutics (eds., Banker, G. & Rhodes, C.) pp. 355-425 (1990).
Shangraw, R., "Specialty Tablet and Capsules," from Modern Pharmaceutics (eds. Banker, G. & Rhodes, C.) pp. 427-440 (1990).
Rudnic et al, Drug Development and industrial Pharmacy; 7(3), pp. 347-358; (1981).
Lowenthal, J. Pham Sci, vol. 61; No. 11, Nov. 1972, pp. 1695-1711.
Holstius et al.; J. Amer. Pharm, Sci (1952), 41,505.
Patel et al., Indian J. Pharm., 26,313 (1964).
Patel, et al., Indian J. Pharm., 28,244 (1966).
Smeczi, et al. Acta Pharm. Hungary., 40,124 (1970).
Billups et al., Amer J. Pharm. 136, 25 (1964).
Patel, et al., Indian J. Pharm., 25,220 (1963).
Salo et al, Pharmzhl, 20,5 (1965)--Int. Pharm Abst 3, 1342d (1966).
Birmancevic et al, Arh. Farm. (1981), 31 (1-2), 45-54.
Birmancevic et al., Acta, Pharmaceutica Jugoslavia (1974), 24, pp. 237-240.
Birmancevic et al. Arch. Farm (1978), 28, 21-28.
Borzonuv et al., Chem Abstr., 69 1097q (1968).
Borzonuv et al., Chem Abst., 71 3385y (1969).
Schmeczi, et al. Chem Abst. 70, 14395q (1969).
Saufiulin, et al., Chem Abst. 58, 13727a (1963).
Kuever et al., J. American Pharm. Ass. Sci, 17,365 (1928).
Shotton et al. J. Pharm Pharmac., 1972 24, 798-803.
Fielden Krystyna E.
Gamlen Michael J. D.
Bawa Raj
Glaxo Wellcome Inc.
LandOfFree
Water-dispersible tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Water-dispersible tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water-dispersible tablets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383277